GINA asthma symptom control
Pulmonology
Also known as: GINA-Asthmakontrolle · Asthmakontrolle nach GINA · GINA astım kontrolü · GINA assessment of asthma symptom control
What it is for
GINA (Global Initiative for Asthma) grades recent asthma symptom control in adults, adolescents and children 6-11 years from four yes/no questions about the past 4 weeks.
Classification
| Category | Description |
|---|---|
| Question 1 | daytime asthma symptoms more than twice a week? |
| Question 2 | any night waking due to asthma? |
| Question 3 | short-acting beta2-agonist (SABA) reliever for symptoms more than twice a week? (as-needed ICS-formoterol reliever and a reliever taken before exercise are not counted; ICS: inhaled corticosteroid) |
| Question 4 | any activity limitation due to asthma? |
| Well controlled | none of the four. |
| Partly controlled | 1-2 of the four. |
| Uncontrolled | 3-4 of the four. |
| Second domain | GINA describes asthma control as symptom control plus the risk of future adverse outcomes (exacerbations, persistent airflow limitation, medication side-effects); risk factors are assessed separately, even when symptoms are well controlled. |
Source
Global Strategy for Asthma Management and Prevention, 2026 update
Global Initiative for Asthma (GINA) 2026 strategy report
- Edition
- GINA 2026 strategy report (Box 2-2, updated May 2026)
- Checked on
Summary of the published classification in our own words. Not a substitute for the original publication.
A question about this classification?
Medelix answers clinical questions from guidelines and studies – every statement with its source.